Joan Seoane Selected Research

Joan Seoane Research Topics

Disease

45	Neoplasms (Cancer) 05/2024 - 11/2006
11	Glioma (Gliomas) 01/2022 - 02/2007
9	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 04/2004
6	Breast Neoplasms (Breast Cancer) 05/2024 - 11/2008
6	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2008
6	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2004
4	Circulating Neoplastic Cells 01/2022 - 11/2013
2	Carcinoma (Carcinomatosis) 01/2018 - 11/2013
1	Microsatellite Instability 04/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Lymphoma (Lymphomas) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Medulloblastoma 10/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 12/2018
1	Meningeal Carcinomatosis 11/2015
1	Li-Fraumeni Syndrome 11/2013
1	Cardiotoxicity 09/2012
1	Carcinogenesis 04/2009
1	Colonic Neoplasms (Colon Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 04/2021 - 07/2013
7	Transforming Growth Factor beta (TGF-beta)IBA 04/2015 - 04/2004
5	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 02/2014
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2024 - 10/2018
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 02/2012
3	Phosphotransferases (Kinase)IBA 11/2023 - 02/2015
3	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2020
3	AntigensIBA 10/2022 - 10/2018
3	Circulating Tumor DNAIBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2008
3	Cytostatic AgentsIBA 12/2017 - 10/2002
3	LY-2157299IBA 01/2016 - 02/2015
2	RNA (Ribonucleic Acid)IBA 05/2024 - 12/2019
2	CytokinesIBA 01/2023 - 10/2022
2	Bispecific AntibodiesIBA 10/2022 - 10/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 12/2020 - 11/2015
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 01/2020
2	Cell-Free Nucleic AcidsIBA 01/2020 - 07/2013
2	MicroRNAs (MicroRNA)IBA 01/2020 - 11/2015
2	EnzymesIBA 12/2019 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 11/2015 - 11/2008
2	Lapatinib (GW572016)FDA Link 11/2013 - 11/2008
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2009 - 03/2008
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 05/2024
1	Adenosine Triphosphate (ATP)IBA 04/2024
1	Glucose (Dextrose)FDA LinkGeneric 03/2024
1	Oxygen (Dioxygen)IBA 03/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2024
1	Leukemia Inhibitory FactorIBA 01/2023
1	epidermal growth factor receptor VIIIIBA 10/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	selinexorIBA 08/2020
1	ibrutinibIBA 08/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	ProteomeIBA 12/2019
1	MethyltransferasesIBA 12/2019
1	5-Methylcytosine (5 Methylcytosine)IBA 12/2019
1	Neutralizing AntibodiesIBA 11/2019
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018
1	5-hydroxymethylcytosineIBA 01/2018
1	Insulin-Like PeptidesIBA 01/2016
1	Immunomodulating AgentsIBA 11/2015
1	FHDIBA 02/2015
1	Syntaxin 1IBA 01/2015
1	SNARE Proteins (SNAREs)IBA 01/2015
1	Insulin-Like Growth Factor Binding Protein 2IBA 06/2014
1	Peptide Hydrolases (Proteases)FDA Link 06/2014
1	plerixafor FDA Link 09/2012
1	CXCR ReceptorsIBA 09/2012
1	Transforming Growth Factor beta2IBA 04/2009
1	InterleukinsIBA 03/2008
1	Platelet Factor 4IBA 03/2008
1	Parathyroid Hormone-Related ProteinIBA 03/2008
1	von Willebrand FactorIBA 03/2008

Therapy/Procedure

19	Therapeutics 03/2024 - 11/2013
6	Immunotherapy 10/2023 - 11/2019
2	Aftercare (After-Treatment) 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 11/2015
2	Precision Medicine 01/2017 - 07/2013
1	Neoadjuvant Therapy 05/2024
1	Operative Surgical Procedures 01/2018